AC Immune SAACIUEarnings & Financial Report
Nasdaq
ACIU Q2 2025 Key Financial Metrics
Revenue
$1.4M
Gross Profit
N/A
Operating Profit
$-21.3M
Net Profit
$-23.3M
Gross Margin
N/A
Operating Margin
-1484.5%
Net Margin
-1622.4%
YoY Growth
90.1%
Financial Flow
AC Immune SA Q2 2025 Financial Summary
AC Immune SA reported revenue of $1.4M (up 90.1% YoY) for Q2 2025, with a net profit of $-23.3M (up 6.9% YoY) (-1622.4% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $1.4M |
|---|---|
| Net Profit | $-23.3M |
| Gross Margin | N/A |
| Operating Margin | -1484.5% |
| Report Period | Q2 2025 |
AC Immune SA Quarterly Revenue & Net Profit History
AC Immune SA quarterly results over the last 3 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 2025 | $1.4M | +90.1% | $-23.3M | -1622.4% |
| Q2 2024 | $755.7K | — | $-25.0M | -3313.0% |
| Q3 2022 | $4.3M | — | $-14.9M | -343.6% |
Income Statement
| Q3 2022 | Q2 2024 | Q2 2025 | |
|---|---|---|---|
| Revenue | $4.3M | $755700 | $1.4M |
| YoY Growth | N/A | N/A | 90.1% |
Balance Sheet
| Q3 2022 | Q2 2024 | Q2 2025 | |
|---|---|---|---|
| Assets | $226.1M | $261.3M | $209.2M |
| Liabilities | $17.1M | $125.5M | $127.0M |
| Equity | $209.1M | $135.8M | $82.2M |
Cash Flow
No data available for this period